Israel to expand use of COVID drug that gets 88% of patients out of hospital
MesenCure, an Israeli COVID-19 treatment, has been approved for expanded use by the Health Ministry.

https://www.jpost.com/health-science...ospital-676397

The Health Ministry has approved the expanded use of an innovative COVID-19 treatment that helped 14 out of 16 severe patients who took it to be released from the hospital one day after receiving their final dose.
The drug, MesenCure, has been being tested by Rambam Medical Center as part of a Phase I/II trial. The ministry has approved allowing any Israeli hospital interested to take part in the Phase II trial and to use the drug for additional approved patients.
The goal of the expanded trial, which will include a minimum of 50 patients, is to confirm the safety and efficacy of the drug, which was developed by Bonus BioGroup.